Tag: LVEF

1. In patients with stable heart failure, adrenergic co-transmitter neuropeptide Y (NPY) levels can identify patients at risk of adverse outcomes related to hyperadrenergic activation Evidence Rating Level: 2 (Good) The adrenergic co-transmitter neuropeptide Y (NPY) is one of the neurotransmitters released by cardiac sympathetic nerve terminals, and may represent an...

Association of Intrinsic Brain Architecture With Changes in Attentional and Mood Symptoms During Development 1. Resting-state functional connectivity between several brain regions may serve as a useful biomarker to predict future neuropsychiatric symptoms such as attention deficits, anxiety, and depression in children. Evidence Rating Level: 2 (Good) Neurodevelopment has become an important...

1. In this randomized, placebo controlled study of HER2-positive breast cancer patients receiving trastuzumab, use of preventative lisinopril or carvedilol did not significantly reduce cardiotoxicity compared to placebo. 2. For patients undergoing therapy with trastuzumab combined with anthracyclines, use of either carvedilol or lisinopril was associated with a reduced risk...